Select your language
06.08.2026
First Tuberculosis Samples Arrive in the Sequencing Lab
Targeted Next-Generation Sequencing (tNGS), endorsed by the World Health Organization since 2023, can help close critical gaps in the diagnosis of drug-resistant tuberculosis (DR-TB). The technology enables the rapid and comprehensive detection of genetic mutations in the bacterium Mycobacterium tuberculosis that cause resistance to antibiotics. By identifying these resistance-conferring mutations early, clinicians
28.07.2026
Tuberculosis remains the world’s deadliest infectious disease caused by a single pathogen. In 2024, an estimated 10.7 million people worldwide developed tuberculosis, and 1.23 million died from the disease. The situation is particularly critical for drug-resistant tuberculosis: only around two in five affected individuals had access to treatment in 2024. Moreover, treatment outcomes remain substantially poorer than for drug-susceptible tuberculosis.
24.07.2026
The first online lecture series on infectious diseases organized as part of the BREATHE project concluded with an interactive “Infectious Diseases Jeopardy” quiz. Dr Diana Udovenko achieved the highest score and received a Littmann stethoscope in recognition of her quick and precise answers.
7. - 9. September 2026
Borstel
28.-29.09.2026Medical Campus of the University of Cologne, Germany
5. November 2026Borstel
